Barclays’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $258M | Buy |
1,166,960
+121,221
| +12% | +$33.5M | 0.05% | 239 |
|
|
2026
Q1 | $309M | Sell |
1,045,739
-314,988
| -23% | -$93.6M | 0.07% | 199 |
|
|
2025
Q4 | $372M | Sell |
1,360,727
-162,218
| -11% | -$44.1M | 0.09% | 173 |
|
|
2025
Q3 | $411M | Buy |
1,522,945
+491,481
| +48% | +$134M | 0.09% | 155 |
|
|
2025
Q2 | $284M | Sell |
1,031,464
-58,124
| -5% | -$15.8M | 0.07% | 202 |
|
|
2025
Q1 | $289M | Sell |
1,089,588
-4,107
| -0.4% | -$1.01M | 0.08% | 180 |
|
|
2024
Q4 | $254M | Sell |
1,093,695
-6,912
| -0.6% | -$1.59M | 0.07% | 182 |
|
|
2024
Q3 | $243M | Sell |
1,100,607
-22,459
| -2% | -$4.65M | 0.06% | 217 |
|
|
2024
Q2 | $221M | Sell |
1,123,066
-550,568
| -33% | -$114M | 0.07% | 212 |
|
|
2024
Q1 | $360M | Buy |
1,673,634
+482,929
| +41% | +$101M | 0.13% | 133 |
|
|
2023
Q4 | $251M | Sell |
1,190,705
-414,506
| -26% | -$88.4M | 0.09% | 198 |
|
|
2023
Q3 | $321M | Buy |
1,605,211
+386,730
| +32% | +$76.9M | 0.2% | 98 |
|
|
2023
Q2 | $226M | Buy |
1,218,481
+577,293
| +90% | +$107M | 0.14% | 139 |
|
|
2023
Q1 | $123M | Sell |
641,188
-231,097
| -26% | -$41.8M | 0.06% | 224 |
|
|
2022
Q4 | $147M | Buy |
872,285
+124,994
| +17% | +$21.7M | 0.07% | 206 |
|
|
2022
Q3 | $132M | Buy |
747,291
+101,010
| +16% | +$20M | 0.14% | 144 |
|
|
2022
Q2 | $132M | Sell |
646,281
-252,796
| -28% | -$53.6M | 0.08% | 184 |
|
|
2022
Q1 | $214M | Sell |
899,077
-201,419
| -18% | -$47.3M | 0.17% | 126 |
|
|
2021
Q4 | $251M | Buy |
1,100,496
+17,569
| +2% | +$3.87M | 0.09% | 175 |
|
|
2021
Q3 | $209M | Buy |
1,082,927
+152,861
| +16% | +$31M | 0.09% | 172 |
|
|
2021
Q2 | $198M | Buy |
930,066
+146,062
| +19% | +$30.8M | 0.09% | 176 |
|
|
2021
Q1 | $160M | Buy |
784,004
+56,964
| +8% | +$11.2M | 0.09% | 190 |
|
|
2020
Q4 | $132M | Buy |
727,040
+69,909
| +11% | +$11.9M | 0.07% | 218 |
|
|
2020
Q3 | $110M | Buy |
657,131
+148,560
| +29% | +$25M | 0.07% | 216 |
|
|
2020
Q2 | $82.7M | Buy |
508,571
+30,975
| +6% | +$5.55M | 0.06% | 223 |
|
|
2020
Q1 | $82.6M | Sell |
477,596
-257,628
| -35% | -$51.3M | 0.07% | 197 |
|
|
2019
Q4 | $148M | Buy |
735,224
+25,555
| +4% | +$5.24M | 0.08% | 193 |
|
|
2019
Q3 | $150M | Sell |
709,669
-70,921
| -9% | -$14.8M | 0.09% | 169 |
|
|
2019
Q2 | $152M | Buy |
780,590
+180,834
| +30% | +$33.3M | 0.09% | 179 |
|
|
2019
Q1 | $98.7M | Sell |
599,756
-22,082
| -4% | -$3.9M | 0.07% | 241 |
|
|
2018
Q4 | $117M | Buy |
621,838
+50,408
| +9% | +$9.31M | 0.09% | 161 |
|
|
2018
Q3 | $97.3M | Buy |
571,430
+136,168
| +31% | +$22.9M | 0.07% | 215 |
|
|
2018
Q2 | $71.3M | Sell |
435,262
-305,180
| -41% | -$49.8M | 0.06% | 263 |
|
|
2018
Q1 | $120M | Buy |
740,442
+216,799
| +41% | +$34.5M | 0.09% | 183 |
|
|
2017
Q4 | $76.5M | Buy |
523,643
+200,859
| +62% | +$28.6M | 0.06% | 255 |
|
|
2017
Q3 | $43.8M | Buy |
322,784
+100,711
| +45% | +$12.7M | 0.05% | 343 |
|
|
2017
Q2 | $27.8M | Buy |
222,073
+102,465
| +86% | +$12.3M | 0.03% | 460 |
|
|
2017
Q1 | $14.2M | Sell |
119,608
-25,396
| -18% | -$3.05M | 0.02% | 695 |
|
|
2016
Q4 | $16.7M | Buy |
145,004
+28,882
| +25% | +$3.21M | 0.02% | 679 |
|
|
2016
Q3 | $12.1M | Sell |
116,122
-55,977
| -33% | -$5.84M | 0.01% | 762 |
|
|
2016
Q2 | $16.8M | Buy |
172,099
+66,556
| +63% | +$6.29M | 0.02% | 594 |
|
|
2016
Q1 | $10.1M | Sell |
105,543
-36,799
| -26% | -$3.35M | 0.02% | 758 |
|
|
2015
Q4 | $12.8M | Sell |
142,342
-66,390
| -32% | -$6.25M | 0.02% | 770 |
|
|
2015
Q3 | $19.2M | Sell |
208,732
-66,544
| -24% | -$6.33M | 0.02% | 617 |
|
|
2015
Q2 | $25.6M | Sell |
275,276
-79,029
| -22% | -$7.37M | 0.03% | 536 |
|
|
2015
Q1 | $33.3M | Buy |
354,305
+104,666
| +42% | +$9.7M | 0.04% | 460 |
|
|
2014
Q4 | $22M | Sell |
249,639
-211,504
| -46% | -$17.9M | 0.02% | 709 |
|
|
2014
Q3 | $36.4M | Buy |
461,143
+299,477
| +185% | +$22.6M | 0.04% | 444 |
|
|
2014
Q2 | $11.3M | Sell |
161,666
-121,289
| -43% | -$8.54M | 0.01% | 1056 |
|
|
2014
Q1 | $20.9M | Sell |
282,955
-82,323
| -23% | -$6.21M | 0.02% | 657 |
|
|
2013
Q4 | $28.5M | Sell |
365,278
-30,876
| -8% | -$2.42M | 0.03% | 575 |
|
|
2013
Q3 | $28.9M | Buy |
396,154
+18,420
| +5% | +$1.36M | 0.03% | 496 |
|
|
2013
Q2 | $28.7M | Buy |
+377,734
| New | +$24.8M | 0.04% | 463 |
|
Other funds holding CME
Barclays's CME Position: Q2 2026 in Review
Barclays increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $33.5M and bringing the position to 1,166,960 shares worth $258M. The position accounts for 0.05% of the portfolio, ranked #239.
Barclays first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $411M in Q3 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Barclays held 1,166,960 shares of CME Group worth $258M as of Q2 2026.
- Barclays bought 121,221 CME Group shares in Q2 2026, an estimated $33.5M.
- CME Group made up 0.05% of Barclays's portfolio in Q2 2026, its #239 holding.
- Barclays first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
- Barclays's CME Group position peaked at $411M in Q3 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.